ARTICLE | Top Story
Novartis picks up Emisphere option
February 17, 2000 8:00 AM UTC
Novartis (SWX:NOVN) exercised its option to acquire exclusive worldwide development and commercialization rights from EMIS to oral salmon calcitonin to treat osteoporosis. The product was formulated u...